Search results
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News· 8 hours agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
AOL· 8 hours agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update their formulas for fall doses, in an attempt to target the KP.2 strain ...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 13 hours agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
Is It Too Late to Buy Pfizer Stock? | The Motley Fool
The Motley Fool· 1 day agoAre Pfizer's (PFE -0.43%) best days behind it? If the stock's critics are to be believed, the answer...
Is It Too Late to Buy Pfizer Stock?
The Motley Fool via AOL· 1 day agoTo make matters worse, the forces behind this purported decline do not imply room for recovery. As shown on the chart, Pfizer's performance during the...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 3 days agoPfizer is competing against GSK's Arexvy, which hit the market about the same time in 2023. Moderna...
Here's To Science! Pfizer, Moderna Look To Combo Flu/COVID Vaccines
MediaPost· 5 days agoAlbert Bourla, Pfizer’s chief executive officer, acknowledged on Monday that, because the company’s stock price was down at the time, he gave the final sign-off on running ...
Childress Capital Advisors LLC Has $583,000 Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 1 day agoChildress Capital Advisors LLC boosted its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 2.2% during the 4th quarter, according to its most recent 13F filing with the Securities ...
Pfizer: An Oversold Pharma Stock in Recovery
GuruFocus.com via Yahoo Finance· 3 days agoThe latter two metrics have dropped because revenue fell quickly and the costs induced by a high inflationary environment have risen. This combination...
FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot
Reuters via Yahoo News· 1 day agoThe Food and Drug Administration's change in recommendation, in an update dated Thursday, comes even...
